Medtronic Management
Management criteria checks 2/4
Medtronic's CEO is Geoff Martha, appointed in Apr 2020, has a tenure of 4.67 years. total yearly compensation is $20.08M, comprised of 6.7% salary and 93.3% bonuses, including company stock and options. directly owns 0.006% of the company’s shares, worth $6.38M. The average tenure of the management team and the board of directors is 3.7 years and 7.8 years respectively.
Key information
Geoff Martha
Chief executive officer
US$20.1m
Total compensation
| CEO salary percentage | 6.7% |
| CEO tenure | 4.7yrs |
| CEO ownership | 0.006% |
| Management average tenure | 3.7yrs |
| Board average tenure | 7.8yrs |
Recent management updates
Recent updates
Medtronic (NYSE:MDT) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Dec 03
Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing
Nov 19Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns
Nov 08Medtronic: Undervalued But Trapped In Slow Growth (Rating Downgrade)
Oct 31Is It Time To Consider Buying Medtronic plc (NYSE:MDT)?
Oct 13Medtronic: Undervalued Dividend Aristocrat With High Margins
Oct 10An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 33% Undervalued
Sep 30Medtronic (NYSE:MDT) Boosts FY 2025 Guidance Amid Strong Q1 Earnings and Strategic Share Buybacks
Sep 16Medtronic: An Undervalued Stock With Durable Competitive Advantages
Sep 16Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Sep 05Medtronic: Is The Company Back?
Aug 26Medtronic: Still A Buy Before Earnings
Aug 17Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down
Aug 08Medtronic: An Out Of Favor Healthcare Stock With A Pulse On Profit Potential
Jul 16At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?
Jul 11Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year
Jun 27Medtronic: Why I Disagree With The Crowd
Jun 14Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's
Jun 10Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued
May 27Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70
May 26These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well
May 22Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release
May 13Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?
May 0135% Undervalued? Medtronic's Future Looks Very Bright
Apr 12Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now
Mar 27Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth
Mar 11Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69
Mar 11Medtronic: Its Recent Beat Proves That It Continues To Be A Rock
Feb 25Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 22Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility
Feb 16A Look At The Fair Value Of Medtronic plc (NYSE:MDT)
Jan 31Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?
Jan 16Medtronic Stock's Rally Is Set To Continue
Jan 11Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings
Dec 29Medtronic: The GLP-1 Drug Headwinds Are Overblown
Dec 103.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic
Nov 28Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings
Nov 17Medtronic Faces Potential Decline Despite Financial Strength
Oct 29Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%
Sep 27CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Oct 25 2024 | n/a | n/a | US$4b |
| Jul 26 2024 | n/a | n/a | US$4b |
| Apr 26 2024 | US$20m | US$1m | US$4b |
| Jan 26 2024 | n/a | n/a | US$4b |
| Oct 27 2023 | n/a | n/a | US$4b |
| Jul 28 2023 | n/a | n/a | US$4b |
| Apr 28 2023 | US$15m | US$1m | US$4b |
| Jan 27 2023 | n/a | n/a | US$4b |
| Oct 28 2022 | n/a | n/a | US$4b |
| Jul 29 2022 | n/a | n/a | US$5b |
| Apr 29 2022 | n/a | n/a | US$5b |
| Jan 28 2022 | n/a | n/a | US$5b |
| Oct 29 2021 | n/a | n/a | US$5b |
| Jul 30 2021 | n/a | n/a | US$4b |
| Apr 30 2021 | US$18m | US$1m | US$4b |
| Jan 29 2021 | n/a | n/a | US$3b |
| Oct 30 2020 | n/a | n/a | US$4b |
| Jul 31 2020 | n/a | n/a | US$4b |
| Apr 24 2020 | US$6m | US$905k | US$5b |
| Jan 24 2020 | n/a | n/a | US$5b |
| Oct 25 2019 | n/a | n/a | US$5b |
| Jul 26 2019 | n/a | n/a | US$4b |
| Apr 26 2019 | US$4m | US$693k | US$5b |
Compensation vs Market: Geoff's total compensation ($USD20.08M) is above average for companies of similar size in the US market ($USD12.85M).
Compensation vs Earnings: Geoff's compensation has increased by more than 20% in the past year.
CEO
Geoff Martha (54 yo)
4.7yrs
Tenure
US$20,084,630
Compensation
Mr. Geoffrey Straub Martha, also known as Geoff, serves as Director at Medtronic plc since November 01, 2019 and serves as its Chief Executive Officer since April 27, 2020. He serves as Director of NextEra...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 4.7yrs | US$20.08m | 0.0061% $ 6.4m | |
| Executive VP & President of Cardiovascular Portfolio | no data | US$6.55m | 0.0025% $ 2.6m | |
| Executive VP & President of Neuroscience Portfolio | 5.1yrs | US$6.44m | 0.00095% $ 987.1k | |
| Executive Vice President of Global Operations & Supply Chain | 3.7yrs | US$7.66m | 0.0015% $ 1.5m | |
| Senior Vice President of Global Financial Planning and Analysis & Interim CFO | less than a year | no data | 0.00060% $ 623.4k | |
| Senior Vice President of Global Operations and Business Services | 8.2yrs | no data | no data | |
| Senior VP | 3.5yrs | no data | 0.0022% $ 2.3m | |
| Senior VP and Chief Technology & Innovation Officer | 1.5yrs | no data | no data | |
| Senior VP and Chief Scientific & Medical Officer | 2.7yrs | no data | no data | |
| VP & Head of Investor Relations | 9.5yrs | no data | no data | |
| Executive VP | 2.8yrs | US$11.72m | 0.0021% $ 2.2m | |
| Senior VP & Chief Communications Officer | 3.9yrs | no data | no data |
3.7yrs
Average Tenure
59yo
Average Age
Experienced Management: MDT's management team is considered experienced (3.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 5.1yrs | US$20.08m | 0.0061% $ 6.4m | |
| Independent Director | 11.9yrs | US$365.06k | 0.0012% $ 1.2m | |
| Independent Director | 17.9yrs | US$350.06k | 0.0015% $ 1.6m | |
| Independent Director | 9.9yrs | US$385.06k | 0.0034% $ 3.5m | |
| Lead Independent Director | 9.9yrs | US$410.06k | 0.0028% $ 2.9m | |
| Independent Director | 5.8yrs | US$370.06k | 0.00048% $ 498.7k | |
| Independent Director | 10.9yrs | US$370.06k | 0.0010% $ 1.1m | |
| Independent Director | 2.5yrs | US$350.06k | 0.00012% $ 124.7k | |
| Independent Director | 4.3yrs | US$370.06k | 0.00032% $ 332.5k | |
| Independent Director | 1.5yrs | US$306.97k | 0% $ 0 |
7.8yrs
Average Tenure
63yo
Average Age
Experienced Board: MDT's board of directors are considered experienced (7.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 01:44 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/10/25 |
| Annual Earnings | 2024/04/26 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medtronic plc is covered by 65 analysts. 31 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kadambari Daptardar | Accountability Research Corporation |
| Harshit Gupta | Accountability Research Corporation |
| David Toung | Argus Research Company |